For research use only

Performance · 15 products

Performance and growth-hormoneresearch peptides.

Growth-hormone secretagogues and related research peptides, including CJC-1295, ipamorelin, sermorelin, tesamorelin, GHRP-2, GHRP-6, and IGF-1 LR3. Third-party tested to 99% purity with a per-batch Certificate of Analysis. Research use only.

Compound reference

What is inthis collection.

GHRH analogue

CJC-1295 (no DAC)(Modified GRF (1-29))

Target: GHRH receptor

The first 29 amino acids of growth hormone-releasing hormone with four amino acid substitutions that improve stability. Without DAC it has a short half-life.

Studied in pituitary research on pulsatile growth hormone release, often alongside ghrelin receptor agonists.

GHRH analogue + ghrelin receptor agonist

CJC-1295 + Ipamorelin

Target: GHRH receptor and GHS-R1a

A combined preparation of Modified GRF (1-29) and ipamorelin, pairing GHRH receptor and ghrelin receptor activity in one vial.

Supplied for research on the combined effect of GHRH and ghrelin receptor signaling on pituitary growth hormone release.

Long-acting GHRH analogue

CJC-1295 with DAC

Target: GHRH receptor

A GHRH analogue with a Drug Affinity Complex that binds serum albumin, extending its half-life from minutes to days.

Studied in endocrine research on sustained GHRH receptor activation and downstream IGF-1 levels.

Growth hormone-releasing hexapeptide

GHRP-2(Pralmorelin)

Target: Ghrelin receptor (GHS-R1a)

A synthetic hexapeptide that acts as an agonist at the ghrelin receptor (GHS-R1a).

Used in pituitary and ghrelin-system research on growth hormone secretion.

Growth hormone-releasing hexapeptide

GHRP-6

Target: Ghrelin receptor (GHS-R1a)

One of the first synthetic growth hormone secretagogues, a hexapeptide agonist of the ghrelin receptor.

A reference compound in ghrelin receptor research, including studies of appetite signaling in animal models.

Growth hormone secretagogue

Hexarelin

Target: Ghrelin receptor (GHS-R1a), CD36

A synthetic hexapeptide ghrelin receptor agonist that also binds the scavenger receptor CD36.

Studied in endocrine research and in cardiovascular models where its CD36 binding is of interest.

Recombinant growth hormone

HGH (Somatropin)(Recombinant human growth hormone)

Target: Growth hormone receptor

A 191-amino-acid recombinant protein identical in sequence to pituitary human growth hormone.

A standard reagent in growth hormone receptor and IGF-1 axis research. Pharmaceutical somatropin is a prescription medicine.

IGF-1 analogue

IGF-1 LR3(Long R3 IGF-1)

Target: IGF-1 receptor

An 83-amino-acid analogue of insulin-like growth factor 1 with an arginine substitution at position 3 and an N-terminal extension that reduce binding to IGF binding proteins.

Widely used in cell culture and bioprocessing to support cell growth, and in IGF-1 receptor signaling research.

Selective growth hormone secretagogue

Ipamorelin

Target: Ghrelin receptor (GHS-R1a)

A pentapeptide ghrelin receptor agonist known for its selectivity: in early studies it released growth hormone without significant effects on cortisol or prolactin.

Studied in pituitary research and as a selective tool compound in the ghrelin system.

GHRH analogue

Sermorelin(GRF (1-29) NH2)

Target: GHRH receptor

The shortest fully active fragment of growth hormone-releasing hormone, residues 1-29 with an amidated C-terminus.

A reference GHRH receptor agonist in pituitary and growth hormone axis research.

Stabilized GHRH analogue

Tesamorelin

Target: GHRH receptor

A full-length (1-44) GHRH analogue with a trans-3-hexenoyl group added to the N-terminus for stability.

Studied in endocrine and visceral adipose tissue research. Pharmaceutical tesamorelin is a prescription medicine.

Other research areas

All products are for in-vitro laboratory research only. Not for human or animal consumption.